The present study also showed that after infection with the Omicron variant of SARS-CoV-2, inflammatory factors (e.g., IL-6, CRP, and PCT) were increased significantly in diabetic patients compared with non-diabetic patients, suggesting that diabetic patients might be more likely to have a hyperinflammatory response to COVID-19. The gene discussed is IL6; the disease is COVID-19.